Ledger.Open graph →
SEC Form D · Amendment · filed October 9, 2015

Tetherex Pharmaceuticals Corp

Offering
$4.0M
Sold
$4.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
OKLAHOMA CITY, OK
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Philip Jones, M.D · Norman, OKDirectorScott Rollins, Ph.D · OKLAHOMA CITY, OKExec · DirectorDavid Keiser · Madison, CTDirectorRussell Rother · OKLAHOMA CITY, OKExecRodger Mcever, M.D · OKLAHOMA CITY, OKDirectorDavid Facloner · Edmond, OKExecRichard Alvarez · Edmond, OKExecTodd Foley · Boston, MADirectorAleem Mawji · Stamford, CTExecJurg Schappi · Dublin, IrelandExecPhilip Jones, M.D · Norman, OKDirectorNicolas Motelay · Dublin, IrelandDirectorRandy Maksymowich · Calgary, Alberta, CanadaExec · DirectorMark Poelzer · Calgary, Alberta, CanadaExec · DirectorKevin Collings · Calgary, Alberta, CanadaExecJames Davis · Calgary, Alberta, CanadaDirectorPaul M. Britton · New York, NYExec · DirectorCorre Partners Management, LLC · New York, NYExecArthur Rosen · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗